Novel miRNA biomarker and treatment of memory impairment

Age associated dementia consist a serious health and social problem for our society, with their prevalence increasing as lifespan expands. Efficient therapeutic strategies to treat memory decline are still missing. Scientists of the University of Göttingen have now developed a new biomarker and medical approach for treatment of dementia and of other memory impairment conditions. This includes discovery of a new microRNA (miRNA) biomarker associated with learning and memory and its therapeutic manipulation, in particular to rescue learning impairment in dementia.

Further Information: PDF

MBM ScienceBridge GmbH
Phone: (0551) 30724-151

Contact
Dr. Jens-Peter Horst

Media Contact

info@technologieallianz.de TechnologieAllianz e.V.

All latest news from the category: Technology Offerings

Back to home

Comments (0)

Write a comment

Newest articles

Lighting up the future

New multidisciplinary research from the University of St Andrews could lead to more efficient televisions, computer screens and lighting. Researchers at the Organic Semiconductor Centre in the School of Physics and…

Researchers crack sugarcane’s complex genetic code

Sweet success: Scientists created a highly accurate reference genome for one of the most important modern crops and found a rare example of how genes confer disease resistance in plants….

Evolution of the most powerful ocean current on Earth

The Antarctic Circumpolar Current plays an important part in global overturning circulation, the exchange of heat and CO2 between the ocean and atmosphere, and the stability of Antarctica’s ice sheets….

Partners & Sponsors